These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 15549295)
1. PET scan with 11C-acetate for the imaging of liver masses: report of a false positive case. Lhommel R; Annet L; Bol A; Gigot JF; Sempoux C; Mathieu I; Seret M; Lonneux M Eur J Nucl Med Mol Imaging; 2005 May; 32(5):629. PubMed ID: 15549295 [No Abstract] [Full Text] [Related]
2. Hepatocelluar carcinoma in an accessory lobe of the liver revealed by 11C-acetate PET with a negative finding on FDG imaging. Huo L; Dang Y; Feng R; Zhuang H; Li F Clin Nucl Med; 2012 Apr; 37(4):393-5. PubMed ID: 22391716 [No Abstract] [Full Text] [Related]
3. Dual time point C-11 acetate PET imaging can potentially distinguish focal nodular hyperplasia from primary hepatocellular carcinoma. Huo L; Wu Z; Zhuang H; Fu Z; Dang Y Clin Nucl Med; 2009 Dec; 34(12):874-7. PubMed ID: 20139820 [TBL] [Abstract][Full Text] [Related]
4. Application of dual phase imaging of 11C-acetate positron emission tomography on differential diagnosis of small hepatic lesions. Huo L; Dang Y; Lv J; Xing H; Li F PLoS One; 2014; 9(5):e96517. PubMed ID: 24816814 [TBL] [Abstract][Full Text] [Related]
5. Novel parameter estimation methods for 11C-acetate dual-input liver model with dynamic PET. Chen S; Feng D IEEE Trans Biomed Eng; 2006 May; 53(5):967-73. PubMed ID: 16686421 [TBL] [Abstract][Full Text] [Related]
6. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383 [TBL] [Abstract][Full Text] [Related]
7. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. Ho CL; Yu SC; Yeung DW J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212 [TBL] [Abstract][Full Text] [Related]
8. Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma. Li S; Beheshti M; Peck-Radosavljevic M; Oezer S; Grumbeck E; Schmid M; Hamilton G; Kapiotis S; Dudczak R; Kletter K Liver Int; 2006 Oct; 26(8):920-7. PubMed ID: 16953831 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma. Territo PR; Maluccio M; Riley AA; McCarthy BP; Fletcher J; Tann M; Saxena R; Skill NJ BMC Med Imaging; 2015 May; 15():15. PubMed ID: 25981587 [TBL] [Abstract][Full Text] [Related]
11. Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma. Lee SJ; Kim SY; Kim KW; Shin YM; Kim HJ; Lee JS; Kim SA Clin Mol Hepatol; 2012 Sep; 18(3):330-5. PubMed ID: 23091816 [No Abstract] [Full Text] [Related]
12. 11C-acetate PET/CT in multicentric angiomyolipoma of the kidney. Ho CL; Chen S; Ho KM; Ng WK; Leung YL; Cheng TK Clin Nucl Med; 2011 May; 36(5):407-8. PubMed ID: 21467870 [No Abstract] [Full Text] [Related]
13. [Usefulness of nonattenuation corrected positron emission tomography image in a patient with hepatocarcinoma treated with chemoembolization]. Orcajo Rincón J; Alonso Farto JC; Rotger Regi A; Zamudio Rodríguez D; Pérez Aradas V Rev Esp Med Nucl; 2010; 29(3):144-5. PubMed ID: 20398967 [No Abstract] [Full Text] [Related]
14. Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography. Chen S; Ho C; Feng D; Chi Z IEEE Trans Med Imaging; 2004 Apr; 23(4):426-32. PubMed ID: 15084068 [TBL] [Abstract][Full Text] [Related]
15. Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma. Lin Y; Jeng LB; Wang HY; Tsai SC; Lin WY; Kao CH Technol Cancer Res Treat; 2015 Oct; 14(5):593-9. PubMed ID: 24945368 [TBL] [Abstract][Full Text] [Related]
16. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms. He YX; Guo QY Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981 [TBL] [Abstract][Full Text] [Related]
17. 11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. Delbeke D; Pinson CW J Nucl Med; 2003 Feb; 44(2):222-3. PubMed ID: 12571213 [No Abstract] [Full Text] [Related]
18. [Malignant tumor with false negative 18F-FDG PET image]. Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging. Beadsmoore CJ; Cheow HK; Sala E; Lomas DJ; Gibbs P; Save V; Alison ME; Balan KK Br J Radiol; 2005 Sep; 78(933):841-4. PubMed ID: 16110108 [TBL] [Abstract][Full Text] [Related]
20. Value of PET/CT in the management of primary hepatobiliary tumors, part 2. Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]